Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...
Not long ago, launching a business meant building a product and finding customers. Today, it often means something ...
New discipline addresses gap between brand intent and AI-generated descriptions as 95% of B2B buyers plan to use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results